Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 5Phase 3 4Phase 1/2 4Phase 4 3Phase 1 3Phase EARLY_PHASE1 1

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 227INDUSTRY 187NIH 19NETWORK 7OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4Lymphoid 1

Conditions

Stomach Neoplasms 8Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasms 4Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Parasomnias 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Melanoma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Head and Neck Neoplasms 2HIV Infections 2Fatigue 2Erectile Dysfunction 2Carcinoma, Hepatocellular 2Vitamin D Deficiency 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Untreated Advanced Non-small Cell Lung Cancer 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1

Interventions

pegfilgrastim 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER_GOV × Multiple Myeloma × Clear all
NCT07477912 2026-03-17

MSTH-CAR001

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 1/2 Recruiting
30 enrolled
Plasma cell

Multiple Myeloma

NCT05243212 2024-01-31

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Sheba Medical Center

Phase 1/2 Recruiting
75 enrolled
Plasma cell

Multiple Myeloma

NCT03322735 2017-12-29

Study of BCMA CAR-T in Multiple Myeloma

Henan Cancer Hospital

Phase 1/2 Unknown
10 enrolled
Plasma cell

Multiple Myeloma

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

Sheba Medical Center

Phase 1/2 Unknown
24 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡